Evidence map›Paper›PMID 28851116›Full record

ArticleChembiochem : a European journal of chemical biology2017

A Comprehensive Study of the Interaction between Peptidoglycan Fragments and the Extracellular Domain of Mycobacterium tuberculosis Ser/Thr Kinase PknB.

Qianqian Wang, Roberta Marchetti, Sladjana Prisic, Kentaro Ishii, Yohei Arai, Ippei Ohta, Shinsuke Inuki, Susumu Uchiyama, Alba Silipo, Antonio Molinaro and 3 more

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Qianqian WangFaculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Yokohama, Kanagawa, 223-8522, Japan.
Roberta MarchettiDepartment of Chemical Sciences, University of Naples "Federico II", Via Cinthia 4, 80126, Napoli, Italy.
Sladjana PrisicDivision of Infectious Disease, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Kentaro IshiiOkazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki, Aichi, 444-8787, Japan.
Yohei AraiFaculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Yokohama, Kanagawa, 223-8522, Japan.
Ippei OhtaFaculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Yokohama, Kanagawa, 223-8522, Japan.
Shinsuke InukiFaculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Yokohama, Kanagawa, 223-8522, Japan.
Susumu UchiyamaOkazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, 5-1 Higashiyama, Myodaiji, Okazaki, Aichi, 444-8787, Japan.
Alba SilipoDepartment of Chemical Sciences, University of Naples "Federico II", Via Cinthia 4, 80126, Napoli, Italy.
Antonio MolinaroGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan.
Robert N HussonDivision of Infectious Disease, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.ORCID 0000-0001-8994-7046
Koichi FukaseGraduate School of Science, Osaka University, Machikaneyama 1-1, Toyonaka, Osaka, 560-0043, Japan.
Yukari FujimotoFaculty of Science and Technology, Keio University, Hiyoshi 3-14-1, Yokohama, Kanagawa, 223-8522, Japan.ORCID 0000-0001-5320-3192
Keio University · JPUniversity of Naples Federico II · ITNational Institutes of Natural Sciences · JPBoston Children's Hospital · USThe University of Osaka · JPUniversity of Hawaiʻi at Mānoa · US

Funding

Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling NetworkR01AI099204 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUSSON, ROBERT N · 2012 to 2016
$6.1M
Characterization of M. tuberculosis kinases PknA &PknBR01AI059702 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI HUSSON, ROBERT N · 2004 to 2008
$1.9M
M tuberculosis PknB: Targeting the Extracellular domainR21AI062275 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI HUSSON, ROBERT N · 2004 to 2005
$504k
NIAID NIH HHS R01 AI059702NIAID NIH HHS R01 AI099204NIAID NIH HHS R21 AI062275
6 · The paper itself

Abstract

The Mycobacterium tuberculosis Ser/Thr kinase PknB is implicated in the regulation of bacterial cell growth and cell division. The intracellular kinase function of PknB is thought to be triggered by peptidoglycan (PGN) fragments that are recognized by the extracytoplasmic domain of PknB. The PGN in the cell wall of M. tuberculosis has several unusual modifications, including the presence of N-glycolyl groups (in addition to N-acetyl groups) in the muramic acid residues and amidation of d-Glu in the peptide chains. Using synthetic PGN fragments incorporating these diverse PGN structures, we analyzed their binding characters through biolayer interferometry (BLI), NMR spectroscopy, and native mass spectrometry (nMS) techniques. The results of BLI showed that muropeptides containing 1,6-anhydro-MurNAc and longer glycan chains exhibited higher binding potency and that the fourth amino acid of the peptide stem, d-Ala, was crucial for protein recognition. Saturation transfer difference (STD) NMR spectroscopy indicated the major involvement of the stem peptide region in the PASTA-PGN fragment binding. nMS suggested that the binding stoichiometry was 1:1. The data provide the first molecular basis for the specific interaction of PGN with PknB and firmly establish PGNs as the effective ligands of PknB.

Indexed as

Carbohydrate ConformationMycobacterium tuberculosisPeptidoglycanProtein Serine-Threonine KinasesPeptidoglycanProtein Serine-Threonine Kinasesbiolayer interferometrybiomolecular interactionsNMR spectroscopypeptidoglycansproteins

Identifiers

PMID28851116
PMCPMC6261334
OpenAlexW2752330901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.